+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Recombinant Proteins Market Size, Share & Trends Analysis Report by Host Cell (Insect Cells, Mammalian), by Application (Research, Therapeutics), by Product & Services, by End-user, by Region, and Segment Forecasts, 2022-2030

  • PDF Icon

    Report

  • 150 Pages
  • August 2022
  • Region: Global
  • Grand View Research
  • ID: 5649352
Description Jump to:

The global recombinant proteins market size is expected to reach USD 5.09 billion by 2030, registering a CAGR of 12.0% over the forecast period, according to this report. Diseases like multiple sclerosis, neutropenia, cerebral apoplexy, anemia, and others, as well as dwarfism, are becoming more common, which is driving up the demand for recombinant protein drugs. Furthermore, the industry is anticipated to expand due to the increased development and research on biologics, which, in turn, are significantly boosting global industry growth. The focus on the development of biosimilars, biologics, and recombinant proteins has increased owing to a rise in the incidence and prevalence of cancer and the expansion of research & development activity.



According to the American Cancer Society, in 2022, there will be 1.9 million new cases of cancer and 609,360 cancer-related deaths. In addition, the expanding application of recombinant proteins in clinical diagnostic methods including ELISA, Western Blotting, and Immunohistochemistry (IHC) is anticipated to fuel market expansion. Due to factors including rising R&D spending, an increase in the number of cancer patients, and the desire for novel & tailored therapies, the global industry is anticipated to expand significantly during the forecast period. Research activity in recombinant protein space has increased in response to the COVID-19 pandemic as a result of efforts to comprehend the dynamics of the virus. The production of recombinant proteins has increased significantly, along with tailored treatment.

In addition, research funding is predicted to become more readily available along with an increase in demand for and production of recombinant proteins, particularly those immune response proteins associated with COVID-19. Therefore, positive effects have been seen for the companies offering products specifically made for COVID-19. Recombinant protein is viewed as a modified version of natural protein that can be produced in a number of ways to improve protein output, create useful commercial goods, and alter gene sequences. The rise in pharmaceutical firms’ R&D expenditures, high incidence of chronic illnesses, an increase in the number of regulatory requirements, and the ongoing need to reduce viral infections are the main drivers of the global industry.

Over the projected period, the global industry is anticipated to be driven by technological advancements in the synthesis of recombinant proteins. For instance, in June 2022, according to the data produced by the National Center for Biotechnology Information, new breeding techniques, such as CRISPR/Cas9, TALEN, and Zinc Finger mediated, as well as transgenic or cis-genic techniques, are emerging technologies that may make it easier for in vitro genetic editing or manipulation of the genes to be approved. In addition, industry participants are anticipated to invest in the region due to the aging population, rising income levels, better healthcare infrastructure, rising healthcare spending, and the advantages of low-cost manufacturing in developing nations, thereby propelling the market growth.

Recombinant Proteins Market Report Highlights

  • By product & services, the product segment accounted for the largest revenue share in 2021. The demand is increasing globally due to the need for recombinant protein products in biomedical research and increased funding for R&D in the fight against cancer
  • The therapeutics application segment held the maximum revenue share in 2021 due to the prevalence of various diseases, such as metabolic disorders, cancer, genetic disorders, and immune diseases
  • The pharma & biotech companies end-user segment led the global industry in 2021 due to the increasing investments by key market players in their R&D segment to increase research productivity and grow their offerings for revenue generation
  • Mammalian systems are widely used in the production of recombinant proteins, thus, this segment accounted for the largest revenue share in 2021
  • North America was the dominant region in 2021 due to an increase in the incidence of chronic diseases, use of cutting-edge treatments, presence of key players, and rise in healthcare spending in the region
  • Asia Pacific is expected to grow at the fastest CAGR over the projected period due to an uptick in R&D activity, an increase in disposable incomes, and a better understanding of protein therapies among patients
  • India and China are additionally anticipated to see rapid growth in the Asia Pacific region


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-Wise Market Estimation Using Bottom-Up Approach
1.7 Global Market: Cagr Calculation
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Primary Sources
1.11 Objectives
1.11.1 Objective 1:
1.11.2 Objective 2:
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Trends & Outlook
3.2 Market Segmentation And Scope
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing Research Activities For Drug Development And Precision Medicine
3.3.1.2 Rising Adoption Of Biologics And Biosimilars
3.3.1.3 Increasing Investments In Research & Development Activities
3.3.2 Market Restraint Analysis
3.3.2.1 Regulatory And Safety Concerns With Protein Production
3.3.2.2 Dearth Of Skilled Personnel And Expertise
3.3.3 Market Opportunity Analysis
3.3.3.1 Declining Cost Of Therapeutics Recombinant Proteins And Advent Of Biosimilars
3.3.3.2 Innovative Techniques Can Decrease The Recombinant Protein Production Cost
3.4 Business Environment Analysis Tools
3.4.1 Swot Analysis, By Pest
3.4.2 Porter’s Five Forces Analysis
3.5 Penetration & Growth Prospect Mapping For Product, 2021
3.6 Recombinant Proteins Market: Covid-19 Impact Analysis
Chapter 4 Product Segment Analysis
4.1 Recombinant Proteins Market: Product Movement Analysis
4.2 Product
4.2.1 Global Recombinant Proteins Product Market, 2018 - 2030 (USD Million)
4.2.2 Cytokines &Growth Factors
4.2.2.1 Global Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
4.2.2.1.1 Interferons
4.2.2.1.1.1 Global Interferons Market, 2018 - 2030 (USD Million)
4.2.2.1.2 Interleukins
4.2.2.1.2.1 Global Interleukins Market, 2018 - 2030 (USD Million)
4.2.2.1.3 Others
4.2.2.1.3.1 Others Cytokines & Growth Factors Market, 2018 - 2030 (USD Million)
4.2.3 Antibodies
4.2.3.1 Global Antibodies Market, 2018 - 2030 (USD Million)
4.2.4 Immune Checkpoint Proteins
4.2.4.1 Global Immune Checkpoint Proteins Market, 2018 - 2030 (USD Million)
4.2.5 Virus Antigens
4.2.5.1 Global Virus Antigens Market, 2018 - 2030 (USD Million)
4.2.6 Enzymes
4.2.6.1 Global Enzymes Market, 2018 - 2030 (USD Million)
4.2.6.1.1 Kinases
4.2.6.1.1.1 Global Kinases Market, 2018 - 2030 (USD Million)
4.2.6.1.2 Metabolic Enzymes
4.2.6.1.2.1 Global Metabolic Enzymes Market, 2018 - 2030 (USD Million)
4.2.6.1.3 Others
4.2.6.1.3.1 Others Enzymes Market, 2018 - 2030 (USD Million)
4.2.7 Recombinant Regulatory Proteins
4.2.7.1 Global Recombinant Regulatory Proteins Market, 2018 - 2030 (USD Million)
4.2.8 Hormones
4.2.8.1 Global Hormones Market, 2018 - 2030 (USD Million)
4.2.9 Others
4.2.9.1 Others Product Market, 2018 - 2030 (USD Million)
4.3 Production Services
4.3.1 Global Recombinant Proteins Production Services Market, 2018 - 2030 (USD Million)
Chapter 5 Application Segment Analysis
5.1 Recombinant Proteins Market: Application Movement Analysis
5.2 Drug Discovery & Development
5.2.1 Global Drug Discovery & Development, 2018 - 2030 (USD Million)
5.3 Therapeutics
5.3.1 Global Therapeutics Market, 2018 - 2030 (USD Million)
5.3.2 Biologics
5.3.2.1 Global Biologics Market, 2018 - 2030 (USD Million)
5.3.3 Vaccines
5.3.3.1 Global Vaccines Market, 2018 - 2030 (USD Million)
5.3.4 Cell & Gene Therapies
5.3.4.1 Global Cell & Gene Therapies Market, 2018 - 2030 (USD Million)
5.3.5 Others
5.3.5.1 Others Therapeutics Market, 2018 - 2030 (USD Million)
5.4 Research
5.4.1 Global Research Market, 2018 - 2030 (USD Million)
5.5 Other
5.5.1 Other Application Market, 2018 - 2030 (USD Million)
Chapter 6 End-User Segment Analysis
6.1 Recombinant Proteins Market: End-User Movement Analysis
6.2 Pharmaceutical & Biotechnology Companies
6.2.1 Global Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
6.3 Academic & Research Institutes
6.3.1 Global Academic & Research Institutes Market, 2018 - 2030 (USD Million)
6.4 Diagnostic Laboratories
6.4.1 Global Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Other End-Users, 2018 - 2030 (USD Million)
Chapter 7 Host-Cells Segment Analysis
7.1 Recombinant Proteins Market: Host-Cells Movement Analysis
7.2 Mammalian Systems
7.2.1 Global Mammalian Systems Market, 2018 - 2030 (USD Million)
7.3 Insects Cells
7.3.1 Global Insects Cells Market, 2018 - 2030 (USD Million)
7.4 Yeast & Fungi
7.4.1 Global Yeast & Fungi Market, 2018 - 2030 (USD Million)
7.5 Bacterial Cells
7.5.1 Global Bacterial Cells Market, 2018 - 2030 (USD Million)
7.6 Others
7.6.1 Other Host-Cells, 2018 - 2030 (USD Million)
Chapter 8 Regional Outlook
8.1 Recombinant Proteins Market: Regional Movement Analysis
8.2 North America
8.2.1 North America Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3.2 U.K.
8.3.2.1 U.K. Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3.3 Germany
8.3.3.1 Germany Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Sain Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4.2 China
8.4.2.1 China Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4.3 India
8.4.3.1 India Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4.4 Japan
8.4.4.1 Japan Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4.5 South Korea
8.4.5.1 South Korea Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.4.5 Australia
8.4.5.1 Australia Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.5.4 Argentina
8.5.4.1 Argentina Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.6 Middle East And Africa (Mea)
8.6.1 Mea Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 South Africa Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.6.3 Uae
8.6.3.1 Uae Recombinant Proteins Market, 2018 - 2030 (USD Million)
8.6.4 Saudi Arabia
8.6.4.1 Saudi Arabia Recombinant Proteins Market, 2018 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 Thermo Fisher Scientific, Inc.
9.3.1.1 Company Overview
9.3.1.2 Financial Performance
9.3.1.3 Product Benchmarking
9.3.1.4 Strategic Initiatives
9.3.2 Abcam plc
9.3.2.1 Company Overview
9.3.2.2 Financial Performance
9.3.2.3 Product/Service Benchmarking
9.3.2.4 Strategic Initiatives
9.3.3 Bio-Rad Laboratories, Inc.
9.3.3.1 Company Overview
9.3.3.2 Financial Performance
9.3.3.3 Product/Service Benchmarking
9.3.3.4 Strategic Initiatives
9.3.4 Bio-Techne Corporation
9.3.4.1 Company Overview
9.3.4.1.1 R&D Systems
9.3.4.2 Financial Performance
9.3.4.3 Product Benchmarking
9.3.4.4 Strategic Initiatives
9.3.5 Merck KGaA
9.3.5.1 Company Overview
9.3.5.2 Financial Performance
9.3.5.3 Product Benchmarking
9.3.5.4 Strategic Initiatives
9.3.6 GenScript Biotech Corporation
9.3.6.1 Company Overview
9.3.6.2 Financial Performance
9.3.6.3 Product Benchmarking
9.3.6.4 Strategic Initiatives
9.3.7 RayBiotech Life, Inc.
9.3.7.1 Company Overview
9.3.7.2 Financial Performance
9.3.7.3 Product Benchmarking
9.3.7.4 Strategic Initiatives
9.3.8 Proteintech Group, Inc.
9.3.8.1 Company Overview
9.3.8.2 Financial Performance
9.3.8.3 Product Benchmarking
9.3.8.4 Strategic Initiatives
9.3.9 Enzo Life Sciences, Inc.
9.3.9.1 Company Overview
9.3.9.2 Financial Performance
9.3.9.3 Product Benchmarking
9.3.9.4 Strategic Initiatives
9.3.10 STEMCELL Technologies Inc
9.3.10.1 Company Overview
9.3.10.2 Financial Performance
9.3.10.3 Product Benchmarking
9.3.10.4 Strategic Initiatives
9.3.11 Sino Biological, Inc.
9.3.11.1 Company Overview
9.3.11.2 Financial Performance
9.3.11.3 Product Benchmarking
9.3.11.4 Strategic Initiatives
9.3.12 Abnova Corporation
9.3.12.1 Company Overview
9.3.12.2 Financial Performance
9.3.12.3 Product Benchmarking
9.3.12.4 Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 4 Global Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 5 Global Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 6 Global Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 7 Global Recombinant Protein Market, by Region, 2018 - 2030 (USD Million)
Table 8 North America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
Table 9 North America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 10 North America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 11 North America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 12 North America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 13 US Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 14 US Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 15 US Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 16 US Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 17 Canada Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 18 Canada Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 19 Canada Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 20 Canada Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 21 Europe Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
Table 22 Europe Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 23 Europe Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 24 Europe Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 25 Europe Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 26 Germany Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 27 Germany Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 28 Germany Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 29 Germany Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 30 UK Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 31 UK Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 32 UK Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 33 UK Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 34 France Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 35 France Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 36 France Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 37 France Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 38 Italy Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 39 Italy Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 40 Italy Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 41 Italy Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 42 Spain Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 43 Spain Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 44 Spain Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 45 Spain Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 51 China Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 52 China Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 53 China Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 54 China Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 55 Japan Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 56 Japan Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 57 Japan Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 58 Japan Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 59 India Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 60 India Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 61 India Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 62 India Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 63 South Korea Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 64 South Korea Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 65 South Korea Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 66 South Korea Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 67 Australia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 68 Australia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 69 Australia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 70 Australia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 71 Latin America Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
Table 72 Latin America Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 73 Latin America Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 74 Latin America Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 75 Latin America Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 76 Brazil Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 77 Brazil Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 78 Brazil Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 79 Brazil Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 80 Mexico Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 81 Mexico Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 82 Mexico Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 83 Mexico Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 84 Argentina Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 85 Argentina Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 86 Argentina Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 87 Argentina Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 88 Middle East & Africa Recombinant Protein Market, by Country, 2018 - 2030 (USD Million)
Table 89 Middle East & Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 90 Middle East & Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 91 Middle East & Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 92 Middle East & Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 93 South Africa Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 94 South Africa Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 95 South Africa Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 96 South Africa Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 97 Saudi Arabia Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 98 Saudi Arabia Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 99 Saudi Arabia Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 100 Saudi Arabia Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
Table 101 UAE Recombinant Protein Market, by Product & Services, 2018 - 2030 (USD Million)
Table 102 UAE Recombinant Protein Market, by Application, 2018 - 2030 (USD Million)
Table 103 UAE Recombinant Protein Market, End-use, 2018 - 2030 (USD Million)
Table 104 UAE Recombinant Protein Market, Host Cell, 2018 - 2030 (USD Million)
List of Figures
FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain-Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Recombinant Protein, Market Segmentation
FIG. 8 Market Snapshot, 2021
FIG. 9 Market Trends & Outlook
FIG. 10 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 11 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 12 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Market Penetration Vs Growth Prospect Mapping, 2021
FIG. 16 Global Recombinant Protein Market: Product & Services Movement Analysis
FIG. 17 Global Recombinant Protein Market, for Product, 2018 - 2030 (USD Million)
FIG. 18 Global Recombinant Protein Market, for Production Services, 2018 - 2030 (USD Million)
FIG. 19 Global Recombinant Protein Market: Application Movement Analysis
FIG. 20 Global Recombinant Protein Market, for Drug Discovery & Development, 2018 - 2030 (USD Million)
FIG. 21 Global Recombinant Protein Market, for Therapeutics, 2018 - 2030 (USD Million)
FIG. 22 Global Recombinant Protein Market, for Research, 2018 - 2030 (USD Million)
FIG. 23 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
FIG. 24 Global Recombinant Protein Market: End Use Movement Analysis
FIG. 25 Global Recombinant Protein Market, for Pharma & Biotechnology Companies, 2018 - 2030 (USD Million)
FIG. 26 Global Recombinant Protein Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
FIG. 27 Global Recombinant Protein Market, for Diagnostic Laboratories, 2018 - 2030 (USD Million)
FIG. 28 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
FIG. 29 Global Recombinant Protein Market: Host Cell Movement Analysis
FIG. 30 Global Recombinant Protein Market, for Mammalian systems, 2018 - 2030 (USD Million)
FIG. 31 Global Recombinant Protein Market, for Insect Cells, 2018 - 2030 (USD Million)
FIG. 32 Global Recombinant Protein Market, for Yeast & Fungi, 2018 - 2030 (USD Million)
FIG. 33 Global Recombinant Protein Market, for Bacterial Cells, 2018 - 2030 (USD Million)
FIG. 34 Global Recombinant Protein Market, for Others, 2018 - 2030 (USD Million)
FIG. 35 Regional Marketplace: Key Takeaways
FIG. 36 Regional Outlook, 2021 & 2030
FIG. 37 Global Recombinant Protein Market: Region Movement Analysis
FIG. 38 North America Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 39 US Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 40 Canada Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 41 Europe Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 42 Germany Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 43 UK Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 44 France Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 45 Italy Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 46 Spain Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 47 Asia Pacific Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 48 Japan Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 49 China Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 50 India Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 51 Australia Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 52 South Korea Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 53 Latin America Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 54 Brazil Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 55 Mexico Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 56 Argentina Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 57 Middle East and Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 58 South Africa Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 59 Saudi Arabia Recombinant Protein Market, 2018 - 2030 (USD Million)
FIG. 60 UAE Recombinant Protein Market, 2018 - 2030 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific, Inc.
  • Abcam plc
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • R&D Systems
  • Merck KGaA
  • GenScript Biotech Corporation
  • RayBiotech Life, Inc.
  • Proteintech Group, Inc.
  • Enzo Life Sciences, Inc.
  • STEMCELL Technologies Inc
  • Sino Biological, Inc.
  • Abnova Corporation

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedAugust 2022
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 2.05 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.09 Billion
Compound Annual Growth Rate12.0%
Regions CoveredGlobal
No. of Companies Mentioned13

Related Topics

Related Reports

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Recombinant Protein Therapeutics CDMO Market Size, Share & Trends Analysis Report By Type (Growth Hormones, Interferons, Vaccines, Immunostimulating Agents, Others), By Source, By Indication, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 173 Pages
  • Global
From
Recombinant Proteins Manufacturing Services Market Size, Share & Trends Analysis Report, By Service Type (Pre-clinical & Clinical Services, Commercial Production), By Host Cell, By End-user, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Recombinant Proteins Manufacturing Services Market Size, Share & Trends Analysis Report, By Service Type (Pre-clinical & Clinical Services, Commercial Production), By Host Cell, By End-user, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Global Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Forecast 2023-2030 - Product Image

Global Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Forecast 2023-2030

  • Report
  • 191 Pages
  • Global
From
Recombinant Proteins Manufacturing Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031 - Product Image

Recombinant Proteins Manufacturing Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • Report
  • 110 Pages
  • Global
From
Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Forecast to 2028 - Product Image

Global Recombinant Proteins Market by Product (Growth Factors, Chemokines, Structural Proteins, Membrane Proteins), Application (Drug Discovery & Development (Biologics, Vaccines, Cell & Gene Therapy), Research, Biopharma Production) & Region - Forecast to 2028

  • Report
  • 408 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.